ROCKVILLE, Md., Aug. 2 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) , a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced it will release results for the second quarter of 2010, on Thursday, August 5, 2010, before the market opens. A full text copy of the release will be disseminated at that time.
Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results at 10:00 AM ET on Thursday, August 5, 2010. Also participating on the call will be Stephanie R. Irish, Acting CFO. To participate in the conference call, dial the appropriate number below shortly before the 10:00 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos.
The teleconference dial-in numbers are as follows: Domestic callers 1-866-788-0544 International callers 1-857-350-1682 Participant Passcode 57802480
The conference call will be broadcast simultaneously and archived on the Company's website, http://www.vandapharma.com/. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Thursday, August 5, 2010, beginning at 1:00 PM ET and will be accessible until Thursday, August 12, 2010, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 89391430.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com/.
Company Contact: Cristina Murphy Communications Manager Vanda Pharmaceuticals Inc. (240) 599-4500 cristina.murphy@vandapharma.com
Vanda Pharmaceuticals Inc.
CONTACT: Cristina Murphy, Communications Manager of Vanda
Pharmaceuticals Inc., +1-240-599-4500, cristina.murphy@vandapharma.com
Web Site: http://www.vandapharma.com/
